annual operating expenses:
$30.84B+$655.00M(+2.17%)Summary
- As of today (May 29, 2025), PFE annual total operating expenses is $30.84 billion, with the most recent change of +$655.00 million (+2.17%) on December 31, 2024.
- During the last 3 years, PFE annual operating expenses has risen by +$4.08 billion (+15.23%).
- PFE annual operating expenses is now -8.82% below its all-time high of $33.82 billion, reached on December 31, 2010.
Performance
PFE Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$6.45B-$2.22B(-25.65%)Summary
- As of today (May 29, 2025), PFE quarterly total operating expenses is $6.45 billion, with the most recent change of -$2.22 billion (-25.65%) on March 29, 2025.
- Over the past year, PFE quarterly operating expenses has dropped by -$851.00 million (-11.66%).
- PFE quarterly operating expenses is now -35.58% below its all-time high of $10.00 billion, reached on December 31, 2008.
Performance
PFE quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
PFE Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.2% | -11.7% |
| 3 y3 years | +15.2% | +12.5% |
| 5 y5 years | +20.7% | +27.3% |
PFE Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +15.2% | -31.4% | +12.5% |
| 5 y | 5-year | at high | +26.7% | -31.4% | +27.3% |
| alltime | all time | -8.8% | +1798.9% | -35.6% | +779.7% |
PFE Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $6.45B(-25.6%) |
| Dec 2024 | $30.84B(+2.2%) | $8.67B(+21.2%) |
| Sep 2024 | - | $7.15B(-7.3%) |
| Jun 2024 | - | $7.72B(+5.8%) |
| Mar 2024 | - | $7.30B(-15.7%) |
| Dec 2023 | $30.18B(+5.1%) | $8.66B(+20.7%) |
| Sep 2023 | - | $7.17B(-2.2%) |
| Jun 2023 | - | $7.33B(+4.3%) |
| Mar 2023 | - | $7.03B(-25.2%) |
| Dec 2022 | $28.71B(+7.3%) | $9.39B(+35.9%) |
| Sep 2022 | - | $6.91B(+3.4%) |
| Jun 2022 | - | $6.68B(+16.7%) |
| Mar 2022 | - | $5.73B(-32.7%) |
| Dec 2021 | $26.76B(+10.0%) | $8.51B(+29.9%) |
| Sep 2021 | - | $6.55B(+7.7%) |
| Jun 2021 | - | $6.08B(+8.0%) |
| Mar 2021 | - | $5.63B(-28.3%) |
| Dec 2020 | $24.34B(-4.7%) | $7.85B(+34.9%) |
| Sep 2020 | - | $5.82B(+3.8%) |
| Jun 2020 | - | $5.61B(+10.7%) |
| Mar 2020 | - | $5.06B(-16.0%) |
| Dec 2019 | $25.54B(+1.7%) | $6.03B(-10.8%) |
| Sep 2019 | - | $6.75B(+3.3%) |
| Jun 2019 | - | $6.54B(+5.0%) |
| Mar 2019 | - | $6.22B(+13.8%) |
| Dec 2018 | $25.11B(-7.8%) | $5.47B(-19.0%) |
| Sep 2018 | - | $6.75B(+3.4%) |
| Jun 2018 | - | $6.53B(+2.8%) |
| Mar 2018 | - | $6.35B(-21.2%) |
| Dec 2017 | $27.25B(+1.7%) | $8.06B(+23.1%) |
| Sep 2017 | - | $6.55B(+1.9%) |
| Jun 2017 | - | $6.42B(+3.3%) |
| Mar 2017 | - | $6.22B(-23.1%) |
| Dec 2016 | $26.79B(+2.2%) | $8.08B(+26.2%) |
| Sep 2016 | - | $6.41B(+3.7%) |
| Jun 2016 | - | $6.18B(+0.9%) |
| Mar 2016 | - | $6.12B(-26.9%) |
| Dec 2015 | $26.23B(-1.1%) | $8.38B(+41.3%) |
| Sep 2015 | - | $5.93B(-1.1%) |
| Jun 2015 | - | $5.99B(+1.1%) |
| Mar 2015 | - | $5.93B(-27.2%) |
| Dec 2014 | $26.53B(+3.5%) | $8.14B(+28.6%) |
| Sep 2014 | - | $6.33B(+0.8%) |
| Jun 2014 | - | $6.28B(+8.7%) |
| Mar 2014 | - | $5.78B(-18.4%) |
| Dec 2013 | $25.63B(-7.7%) | $7.09B(+15.4%) |
| Sep 2013 | - | $6.14B(-1.9%) |
| Jun 2013 | - | $6.26B(+1.9%) |
| Mar 2013 | - | $6.15B(-18.9%) |
| Dec 2012 | $27.76B(-12.5%) | $7.58B(+15.0%) |
| Sep 2012 | - | $6.59B(+0.7%) |
| Jun 2012 | - | $6.54B(-12.2%) |
| Mar 2012 | - | $7.45B(-0.2%) |
| Dec 2011 | $31.73B(-6.2%) | $7.47B(-6.9%) |
| Sep 2011 | - | $8.02B(-4.7%) |
| Jun 2011 | - | $8.41B(+5.6%) |
| Mar 2011 | - | $7.97B(+6.5%) |
| Dec 2010 | $33.82B(+33.1%) | $7.49B(-24.9%) |
| Sep 2010 | - | $9.96B(+19.6%) |
| Jun 2010 | - | $8.33B(+3.7%) |
| Mar 2010 | - | $8.04B(-11.5%) |
| Dec 2009 | $25.40B(-11.1%) | $9.08B(+66.0%) |
| Sep 2009 | - | $5.47B(-3.2%) |
| Jun 2009 | - | $5.65B(+10.7%) |
| Mar 2009 | - | $5.10B(-49.0%) |
| Dec 2008 | $28.59B(+6.5%) | $10.00B(+65.9%) |
| Sep 2008 | - | $6.03B(-9.3%) |
| Jun 2008 | - | $6.65B(+9.7%) |
| Mar 2008 | - | $6.06B(-21.0%) |
| Dec 2007 | $26.84B(+1.5%) | $7.67B(+17.2%) |
| Sep 2007 | - | $6.54B(-3.7%) |
| Jun 2007 | - | $6.79B(+16.3%) |
| Mar 2007 | - | $5.84B(-25.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $26.45B(+1.9%) | $7.79B(+20.7%) |
| Sep 2006 | - | $6.45B(+0.1%) |
| Jun 2006 | - | $6.45B(+11.9%) |
| Mar 2006 | - | $5.76B(-19.4%) |
| Dec 2005 | $25.97B(-0.8%) | $7.15B(+17.3%) |
| Sep 2005 | - | $6.10B(-5.5%) |
| Jun 2005 | - | $6.45B(-4.1%) |
| Mar 2005 | - | $6.73B(+10.5%) |
| Dec 2004 | $26.17B(+5.6%) | $6.09B(-10.0%) |
| Sep 2004 | - | $6.77B(-2.0%) |
| Jun 2004 | - | $6.91B(+7.8%) |
| Mar 2004 | - | $6.41B(-20.3%) |
| Dec 2003 | $24.78B(+54.3%) | $8.03B(+24.1%) |
| Sep 2003 | - | $6.48B(+7.0%) |
| Jun 2003 | - | $6.05B(+52.6%) |
| Mar 2003 | - | $3.97B(-12.0%) |
| Dec 2002 | $16.06B(+10.1%) | $4.51B(+15.4%) |
| Sep 2002 | - | $3.90B(-0.3%) |
| Jun 2002 | - | $3.92B(+5.0%) |
| Mar 2002 | - | $3.73B(+12.9%) |
| Dec 2001 | $14.59B(-7.5%) | $3.30B(-13.2%) |
| Sep 2001 | - | $3.81B(-3.6%) |
| Jun 2001 | - | $3.95B(+8.7%) |
| Mar 2001 | - | $3.63B(-16.0%) |
| Dec 2000 | $15.78B(+0.2%) | $4.33B(+16.9%) |
| Sep 2000 | - | $3.70B(-6.0%) |
| Jun 2000 | - | $3.94B(-3.2%) |
| Mar 2000 | - | $4.06B(-6.1%) |
| Dec 1999 | $15.75B(+15.3%) | $4.33B(+15.5%) |
| Sep 1999 | - | $3.74B(+0.5%) |
| Jun 1999 | - | $3.73B(+58.3%) |
| Mar 1999 | - | $2.35B(-69.6%) |
| Dec 1998 | $13.66B(+106.0%) | $7.75B(+278.3%) |
| Sep 1998 | - | $2.05B(-0.1%) |
| Jun 1998 | - | $2.05B(+14.1%) |
| Mar 1998 | - | $1.80B(-6.0%) |
| Dec 1997 | $6.63B(+14.7%) | $1.91B(+17.6%) |
| Sep 1997 | - | $1.63B(-11.4%) |
| Jun 1997 | - | $1.84B(+11.9%) |
| Mar 1997 | - | $1.64B(+40.9%) |
| Dec 1996 | $5.79B(+2.0%) | $1.17B(-24.7%) |
| Sep 1996 | - | $1.55B(-7.4%) |
| Jun 1996 | - | $1.67B(+14.4%) |
| Mar 1996 | - | $1.46B(-9.3%) |
| Dec 1995 | $5.67B(+21.1%) | $1.61B(+17.5%) |
| Sep 1995 | - | $1.37B(-4.3%) |
| Jun 1995 | - | $1.43B(+7.2%) |
| Mar 1995 | - | $1.34B(+0.5%) |
| Dec 1994 | $4.68B(-7.3%) | $1.33B(+14.3%) |
| Sep 1994 | - | $1.16B(+2.8%) |
| Jun 1994 | - | $1.13B(+7.1%) |
| Mar 1994 | - | $1.06B(-45.2%) |
| Dec 1993 | $5.05B(+25.4%) | $1.93B(+83.2%) |
| Sep 1993 | - | $1.05B(+28.1%) |
| Jun 1993 | - | $821.00M(-19.4%) |
| Mar 1993 | - | $1.02B(-10.1%) |
| Dec 1992 | $4.03B(+7.7%) | $1.13B(+16.8%) |
| Sep 1992 | - | $969.50M(-2.1%) |
| Jun 1992 | - | $989.90M(+6.2%) |
| Mar 1992 | - | $932.20M(-10.0%) |
| Dec 1991 | $3.74B(+12.7%) | $1.04B(+13.0%) |
| Sep 1991 | - | $916.90M(-1.2%) |
| Jun 1991 | - | $928.00M(+8.0%) |
| Mar 1991 | - | $859.10M(-12.0%) |
| Dec 1990 | $3.32B(+16.5%) | $976.80M(+22.3%) |
| Sep 1990 | - | $798.60M(-1.4%) |
| Jun 1990 | - | $810.20M(+10.6%) |
| Mar 1990 | - | $732.60M |
| Dec 1989 | $2.85B(+11.8%) | - |
| Dec 1988 | $2.55B(+13.5%) | - |
| Dec 1987 | $2.24B(+15.5%) | - |
| Dec 1986 | $1.94B(+12.4%) | - |
| Dec 1985 | $1.73B(+6.4%) | - |
| Dec 1984 | $1.62B | - |
FAQ
- What is Pfizer annual total operating expenses?
- What is the all time high annual operating expenses for Pfizer?
- What is Pfizer annual operating expenses year-on-year change?
- What is Pfizer quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Pfizer?
- What is Pfizer quarterly operating expenses year-on-year change?
What is Pfizer annual total operating expenses?
The current annual operating expenses of PFE is $30.84B
What is the all time high annual operating expenses for Pfizer?
Pfizer all-time high annual total operating expenses is $33.82B
What is Pfizer annual operating expenses year-on-year change?
Over the past year, PFE annual total operating expenses has changed by +$655.00M (+2.17%)
What is Pfizer quarterly total operating expenses?
The current quarterly operating expenses of PFE is $6.45B
What is the all time high quarterly operating expenses for Pfizer?
Pfizer all-time high quarterly total operating expenses is $10.00B
What is Pfizer quarterly operating expenses year-on-year change?
Over the past year, PFE quarterly total operating expenses has changed by -$851.00M (-11.66%)